ACG Invests $200 Million to Expand New Capsule Manufacturing Facility in Atlanta
Introduction:
ACG, one of the world’s leading providers of integrated solid-dosage solutions, has announced a $200 million phased investment to set up its first empty capsule manufacturing operations in the United States.
Features:
The new Atlanta facility will manufacture both gelatin and vegetarian (HPMC) hard-shell capsules, meeting the highest global standards of quality, safety, and regulatory compliance.
This development strengthens ACG’s 25-year presence in North America and supports its Make it Better commitment to innovation and sustainable growth.
The first phase, worth $100 million, will support the construction of a modern hard-shell capsule facility in Atlanta, Georgia.
The second phase, also valued at $100 million, will focus on expanding production capacity and technological capabilities. The project is expected to generate more than 200 new jobs.
Operations are expected to commence in early 2027.
Specifications:
| Name | ACG |
| Budget | $200 Million |
| Type | Construction |
| Year of Completion | 2027 |
